Medtronic's Omar Ishrak: Underdeveloped Markets Demand New Delivery Models
This article was originally published in The Gray Sheet
Executive Summary
Medtronic CEO speaks on the need for new health care delivery models to serve the "bottom billion" in developing countries.
You may also be interested in...
Medtronic Mines GE For New Chief; Omar Ishrak Starts In June
Medtronic's incoming CEO has run a similarly sized medical technology business in terms of sales for the past two years, albeit with a focus on diagnostic and monitoring tools rather than therapeutic technologies.
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.